The RPGRIP1L antibody is an immunological reagent designed to bind specifically to the RPGRIP1L protein, a component localized to primary cilia, basal bodies, and centrosomes. This protein is implicated in ciliopathies such as Joubert syndrome and Meckel syndrome, as well as metabolic and oncogenic processes .
RPGRIP1L antibodies are utilized in:
Immunofluorescence (IF): To visualize RPGRIP1L localization at ciliary bases and centrosomes (e.g., colocalization with nephrocystin-4 in retinal cells) .
Co-immunoprecipitation (Co-IP): To study protein interactions, such as RPGRIP1L’s binding with RPGR (retinitis pigmentosa GTPase regulator) .
Western Blot (WB): To validate protein expression levels in tissues or cell lines .
Functional Studies: Investigating RPGRIP1L’s role in proteasomal activity and ciliary signaling .
Ciliopathies: RPGRIP1L antibodies help diagnose mutations (e.g., JBTS7, MKS5) and study mechanisms like disrupted Shh signaling .
Cancer: High RPGRIP1L expression correlates with poor survival in pancreatic adenocarcinoma and modulates chemosensitivity to paclitaxel .
Obesity: Antibodies identified reduced RPGRIP1L expression in neurons with FTO locus variants, linking ciliary dysfunction to metabolic regulation .